10 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 10 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 6, Unknown 2, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Lipid Metabolism Disorder: new trials by email Literature Review of Lipid Metabolism Disorder trials Research Report on Lipid Metabolism Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients Taohong Tongluo Xiaoban Prescription, Fundamental medical treatment - Cerebral Infarction, Chinese Herbal Medicine | Not applicable | Not yet recruiting | Yan Zhu | 160 | 2024-10-01 | 2024-08-14 |
| Preventing Exercise Resistance With Sedentary Interruptions Standing interruptions, Exercise bout, Sedentary - Sedentary Behavior, Lipid Metabolism Disorder | Not applicable | Unknown | Hasselt University | 24 | 2024-02-19 | 2024-03-04 |
| Health Effects of Biostimulated Lettuce in Human Control Group, Biostimulated group - Nutrition, Healthy, Dietary Deficiency | Not applicable | Completed | University of Palermo | 100 | 2023-03-01 | 2023-08-02 |
| Multicomponent Intervention Study- Blood Donors With High Cholesterol Implementation Strategy Bundle, Usual care notification - Lipid Metabolism Disorder | Not applicable | Recruiting | University of Texas Southwestern Medical Center | 100 | 2023-02-27 | 2026-03-17 |
| Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. Obicetrapib, Placebo - Dyslipidemias, High Cholesterol | Phase 3 | Completed | NewAmsterdam Pharma | 354 | 2022-07-25 | 2025-06-11 |
| Impact of Foods on Bile Acids, Metabolites, and Inflammation Lentil, Control - Inflammation, Hypertriglyceridemia | Not applicable | Unknown | Montana State University | 24 | 2022-02-24 | 2023-05-06 |
| Improvement of Nutritional Status and Blood Lipid Profile by Using MCT Oil on Overweight and Obese Women Soya bean oil, MCT oil - Obesity Adult Onset, Lipid Metabolism Disorder | Not applicable | Completed | National Institute of Nutrition, Vietnam | 161 | 2019-09-08 | 2020-09-10 |
| Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus omega-3 polyunsaturated fatty acids, corn oil - Type 2 Diabetes Mellitus, Lipid Metabolism Disorder | Not applicable | Completed | Southeast University, China | 110 | 2019-06-08 | 2023-11-27 |
| Possible Links Between Inflammation and Lipid Metabolism LPS infusion - Sepsis, Inflammation | Not applicable | Completed | Barmherzige Brüder Linz | 10 | 2017-12-20 | 2018-10-17 |
| Almond Consumption and Glycemia Almonds, Control (no nuts) - Glucose Intolerance, Appetite Disorders | Not applicable | Completed | Purdue University | 75 | 2017-08-01 | 2021-01-07 |
| Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers XueZhiKang, Lovastatin - Lipid Metabolism Disorder | Phase 1 | Completed | Luye Pharma Group Ltd. | 20 | 2015-11-01 | 2016-12-05 |
| Effect of a Carbohydrate-rich Diet in Healthy Subjects isocaloric diet, Hypercaloric diet, Liquid meal - Lipid Metabolism Disorder | Not applicable | Completed | Université de Sherbrooke | 14 | 2013-04-10 | 2019-09-12 |
| Lipid Management in Clinical Practice (MK-0524A-115) Lipid Metabolism Disorder | Completed | Merck Sharp & Dohme LLC | 2390 | 2009-10-01 | 2015-08-11 | |
| Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED) ezetimibe - Lipid Metabolism Disorder | Phase 4 | Completed | Organon and Co | 80 | 2004-09-01 | 2024-08-15 |
Lipid Metabolism Disorders (14) · Glucose Metabolism Disorders (2) · Hypercholesterolemia (2) · Inflammation (2) · Metabolic Diseases (2) · Bone Resorption (1) · Cerebral Infarction (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Fatty Liver (1) · Feeding and Eating Disorders (1) · Genetic Diseases, Inborn (1) · Glucose Intolerance (1) · Hyperlipidemias (1) · Hyperlipoproteinemia Type II (1)
Nutritional and Metabolic Diseases (14) · Metabolic Diseases (12) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (3) · Dyslipidemias (2) · Hyperlipidemias (2) · Nutrition Disorders (2) · Signs and Symptoms (2) · Behavior (1) · Body Weight (1) · Bone Diseases (1) · Brain Diseases (1) · Brain Infarction (1) · Brain Ischemia (1) · Cardiovascular Diseases (1)
Calorimetry, Indirect (1) · Control Groups (1) · Corn Oil (1) · Docosahexaenoic Acids (1) · Ezetimibe (1) · Lovastatin (1) · Magnetic Resonance Spectroscopy (1) · Soybean Oil (1) · lentil lectin (1) · xuezhikang (1)
Barmherzige Brüder Linz (1) · Hasselt University (1) · Luye Pharma Group Ltd. (1) · Merck Sharp & Dohme LLC (1) · Montana State University (1) · National Institute of Nutrition, Vietnam (1) · NewAmsterdam Pharma (1) · Organon and Co (1) · Purdue University (1) · Southeast University, China (1) · University of Palermo (1) · University of Texas Southwestern Medical Center (1) · Université de Sherbrooke (1) · Yan Zhu (1)
United States (5) · Canada (2) · Austria (1) · Belgium (1) · China (1) · Czechia (1) · Georgia (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · South Africa (1) · Spain (1) · United Kingdom (1) · Vietnam (1)
Amit Khera, MD (1) · Marc Ditmarsch (1) · Mary P Miles, PhD (1) · Matthias Heinzl, MD (1) · Richard D Mattes, PhD (1) · Sara Baldassano Professor, PhD (1) · Simon LI, M.D. (1) · Tu S Nguyen, PhD. (1)
PMID 18845704, PMID 31843964, PMID 33870714, PMID 34273987, PMID 35616594, PMID 38705341, PMID 41760952, PMID 42400437
R61HL161753 (1)